Bulletin
Investor Alert

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

After Hours

 --Real time quotes

Jan 27, 2022, 5:53 p.m.

ME
/zigman2/quotes/222659849/composite

$

4.23

Change

+0.02 +0.48%

Volume

Volume 2,990

Real time quotes

/zigman2/quotes/222659849/composite

Today's close

$ 4.41

$ 4.21

Change

-0.20 -4.54%

Day low

Day high

$4.17

$4.55

Open

52 week low

52 week high

$3.99

$18.16

Open

Insider Actions for 23andMe Holding Co.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/06/2022 Kathy L. Hibbs
Chief Legal Officer
58,800   Derivative/Non-derivative trans. at $0.42 per share. 24,696
01/05/2022 Steve Lemon
Vice President, Engineering
127,647   Derivative/Non-derivative trans. at $0.23 per share. 29,358
12/03/2021 Sandra Rae Hernández
Director
18,115   Award at $0 per share. 0
12/03/2021 Sandra Rae Hernández
Director
36,231   Award at $0 per share. 0
11/01/2021 Paul D Johnson
VP, General Manager-Consumer
352,004   Award at $0 per share. 0
11/01/2021 Paul D Johnson
VP, General Manager-Consumer
746,213   Award at $0 per share. 0
09/14/2021 Peter J. Taylor
Director
18,421   Award at $0 per share. 0
09/14/2021 Peter J. Taylor
Director
36,842   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
18,421   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
36,842   Award at $0 per share. 0
09/14/2021 Roelof Frederik Botha
Director
18,421   Award at $0 per share. 0
09/14/2021 Richard H. Scheller
Director
18,421   Award at $0 per share. 0
09/14/2021 Patrick Shuao-Fong Chung
Director
18,421   Award at $0 per share. 0
09/14/2021 Neil Mohan
Director
18,421   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
6 Purchases
0 Sales
1,339,010
0
Last 6 months
14 Purchases
0 Sales
1,523,220
0
Last 12 months
14 Purchases
0 Sales
1,523,220
0

Officers and Executives

Ms. Anne E. Wojcicki
Chief Executive Officer & Director
Mr. Steven Schoch
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Dr. Kenneth J. Hillan
Head-Therapeutics
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Ms. Jacquie Cooke Haggarty
VP, Deputy General Counsel & Privacy Officer
Mr. Kent Hillyer
Vice President-Customer Care
Mr. Kumar Iyer
Head-Product
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Vice President & General Manager-Consumer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Ms. Elvia Cowan
Vice President & Controller
Dr. D. Wade Walke
Vice President-Investor Relations
Mr. Fred Kohler
Vice President-People
Ms. Kathy L. Hibbs
Secretary, Chief Legal & Regulatory Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Neil Mohan
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.